Search All UT System Experts

A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer

Sheri K. Dennison, Samuel A. Jacobs, John W. Wilson, Janell Seeger, Terrence P. Cescon, Jane M. Raymond, Charles E. Geyer, Norman Wolmark, Sandra M. Swain

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences